785 related articles for article (PubMed ID: 26527714)
1. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS;
Circulation; 2015 Dec; 132(22):e267-72. PubMed ID: 26527714
[No Abstract] [Full Text] [Related]
2. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS
J Am Coll Cardiol; 2015 Dec; 66(21):2356-2361. PubMed ID: 26542659
[No Abstract] [Full Text] [Related]
3. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Zipes DP; Kovacs RJ;
Circulation; 2015 Dec; 132(22):e256-61. PubMed ID: 26621642
[No Abstract] [Full Text] [Related]
4. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ;
Circulation; 2015 Dec; 132(22):e310-4. PubMed ID: 26621649
[No Abstract] [Full Text] [Related]
5. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Harris KM; Thompson PD; Eichner ER; Steinberg MH;
Circulation; 2015 Dec; 132(22):e343-5. PubMed ID: 26527715
[No Abstract] [Full Text] [Related]
6. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
Bonow RO; Nishimura RA; Thompson PD; Udelson JE;
Circulation; 2015 Dec; 132(22):e292-7. PubMed ID: 26621646
[No Abstract] [Full Text] [Related]
7. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
Link MS; Estes NA; Maron BJ;
Circulation; 2015 Dec; 132(22):e339-42. PubMed ID: 26621653
[No Abstract] [Full Text] [Related]
8. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
Black HR; Sica D; Ferdinand K; White WB;
Circulation; 2015 Dec; 132(22):e298-302. PubMed ID: 26621647
[No Abstract] [Full Text] [Related]
9. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
Estes NA; Kovacs RJ; Baggish AL; Myerburg RJ;
Circulation; 2015 Dec; 132(22):e330-3. PubMed ID: 26621651
[No Abstract] [Full Text] [Related]
10. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.
Mitten MJ; Zipes DP; Maron BJ; Bryant WJ;
Circulation; 2015 Dec; 132(22):e346-9. PubMed ID: 26621654
[No Abstract] [Full Text] [Related]
11. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
Ackerman MJ; Zipes DP; Kovacs RJ; Maron BJ;
Circulation; 2015 Dec; 132(22):e326-9. PubMed ID: 26527716
[No Abstract] [Full Text] [Related]
12. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
Braverman AC; Harris KM; Kovacs RJ; Maron BJ;
Circulation; 2015 Dec; 132(22):e303-9. PubMed ID: 26621648
[No Abstract] [Full Text] [Related]
13. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
Zipes DP; Link MS; Ackerman MJ; Kovacs RJ; Myerburg RJ; Estes NA;
Circulation; 2015 Dec; 132(22):e315-25. PubMed ID: 26621650
[No Abstract] [Full Text] [Related]
14. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology.
Link MS; Myerburg RJ; Estes NA;
Circulation; 2015 Dec; 132(22):e334-8. PubMed ID: 26621652
[No Abstract] [Full Text] [Related]
15. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH;
Circulation; 2015 Dec; 132(22):e262-6. PubMed ID: 26621643
[No Abstract] [Full Text] [Related]
16. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.
Mitten MJ; Zipes DP; Maron BJ; Bryant WJ
J Am Coll Cardiol; 2015 Dec; 66(21):2447-2450. PubMed ID: 26542663
[No Abstract] [Full Text] [Related]
17. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NA; Cooper LT; Link MS; Maron MS;
Circulation; 2015 Dec; 132(22):e273-80. PubMed ID: 26621644
[No Abstract] [Full Text] [Related]
18. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
Van Hare GF; Ackerman MJ; Evangelista JA; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL;
Circulation; 2015 Dec; 132(22):e281-91. PubMed ID: 26621645
[No Abstract] [Full Text] [Related]
19. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ
J Am Coll Cardiol; 2015 Dec; 66(21):2406-2411. PubMed ID: 26542666
[No Abstract] [Full Text] [Related]
20. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Harris KM; Thompson PD; Eichner ER; Steinberg MH
J Am Coll Cardiol; 2015 Dec; 66(21):2444-2446. PubMed ID: 26542668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
